Parkinsons

[PODCAST] Developments in Parkinson’s Diagnosis: New Tests, Alpha-Synuclein, and Looking Forward (Part 2)

0 Comments
27 December 2024
Davis Phinney

In this episode, Dr. Arash Fazl discusses the role of the protein alpha-synuclein in Parkinson’s and how this protein is involved in new diagnostic tests for Parkinson’s. Dr. Fazl also shares how these new tests may contribute to additional exciting developments in the future.

This is part two of a two-part series about Parkinson’s diagnosis. In the first episode, Dr. Fazl described the challenges involved in diagnosing Parkinson’s. This episode picks up in the middle of our conversation with Dr. Fazl, right where we ended the first episode.

This two-part series is sponsored by CND Life sciences, home of the Syn-One Test—the first commercially available skin-based test to help clinicians diagnose Parkinson’s and related disorders.

LISTEN TO THE EPISODE

This podcast is also available on YouTube.

Want to be updated every time we publish a video or podcast? The best way is to subscribe to our YouTube channel by clicking “subscribe” near the top of our channel’s homepage.

Follow us

@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ead439922{display: block!important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ead439922{display: block!important;}}@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ead439922{position: relative !important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ead439922{position: relative !important;}}

Facebook

@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032eb5f21893{display: block!important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032eb5f21893{display: block!important;}}@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032eb5f21893{position: relative !important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032eb5f21893{position: relative !important;}}

Twitter

@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ec2de8420{display: block!important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ec2de8420{display: block!important;}}@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ec2de8420{position: relative !important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ec2de8420{position: relative !important;}}

LinkedIn

@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ec9ae589{display: block!important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ec9ae589{display: block!important;}}@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ec9ae589{position: relative !important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ec9ae589{position: relative !important;}}

YouTube

@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ed3716917{display: block!important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ed3716917{display: block!important;}}@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ed3716917{position: relative !important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ed3716917{position: relative !important;}}

@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ede817156{display: block!important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ede817156{display: block!important;}}@media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-676e0032ede817156{position: relative !important;}}@media screen and (max-width: 767px) {.thegem-vc-text.thegem-custom-676e0032ede817156{position: relative !important;}}

The post [PODCAST] Developments in Parkinson’s Diagnosis: New Tests, Alpha-Synuclein, and Looking Forward (Part 2) appeared first on Davis Phinney Foundation.

#Parkinsons

Posted at Davis Phinney

#Shuffles

Davis Phinney - Parkinsons

Categories

0 Comments

Submit a Comment

Parkinsons, Odd behaviour and Medications

Parkinsons, Odd behaviour and Medications

by | Jan 3, 2021 | ,

Do you have a friend or loved one with Parkinsons ? You reckon that would be bad enough ? Is their behaviour a bit (or a lot or even dangerously) out of character? It may be the drugs they are taking and not their real self or the disease!Please read ALL of this post...

Introduction and Excuse me!

Introduction and Excuse me!

by | Dec 28, 2020 | ,

Pardon me, while I get this social media enterprise working. It has taken me 12 months to get this far with this editorial labyrinth. My former pre Parkinson’s self would have had this whipped up in a week or two, reality changes ability, however I won’t let it kill...

They Call me Shuffles

They Call me Shuffles

by | Dec 27, 2020 | ,

    A diagnosis with Parkinson's changes a lot of things: Motor function, non-motor functions, but maybe even more powerful is the changes in social interactions. I personally don't mind being called "Shuffles" now, I did at first (8 or so years ago I think), I...